Intracerebral Hemorrhagic Stroke

BackgroundIntracerebral hemorrhage (ICH) usually presents as a type of stroke, in which a bleeding occurs within the brain tissue or ventricles. Apart from hypertension, coagulopathy, and anticoagulant therapy, it can also be resulted from brain trauma, aneurysms, arteriovenous malformations, and brain tumors. While quick control of bleeding in the brain is effective, the anti-ischemic treatment can be beneficial for the permanent brain injury following an event.

Model: Intracranial collagenase induced ICH

Standard study duration: 4-8 weeks

Clinical endpoints: Neurologic deficit assessment, magnetic resonance imaging (MRI), hemorrhage size, DSA, physiological parameters (BP, HR, Body Tm), histopathology…

Features: Human similar cerebral structure, spontaneous ICH, designated hemorrhage site with brain stereotaxis, clinical intervention, neuroprotectant, safety assessment and side-effects…

For more information about these models, please contact Mr. James Song,